These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32206843)

  • 1. Vasopressin versus epinephrine as adjunct vasopressors for septic shock.
    Aso S; Matsui H; Fushimi K; Yasunaga H
    Intensive Care Med; 2020 Jul; 46(7):1484-1485. PubMed ID: 32206843
    [No Abstract]   [Full Text] [Related]  

  • 2. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
    Russell JA; Lee T; Singer J; De Backer D; Annane D
    J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.
    Menich BE; Miano TA; Patel GP; Hammond DA
    Ann Pharmacother; 2019 Sep; 53(9):877-885. PubMed ID: 30957512
    [No Abstract]   [Full Text] [Related]  

  • 4. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
    PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing effects of epinephrine, norepinephrine, and vasopressin on survival in a canine model of septic shock.
    Minneci PC; Deans KJ; Banks SM; Costello R; Csako G; Eichacker PQ; Danner RL; Natanson C; Solomon SB
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2545-54. PubMed ID: 15319205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter to the editor: "Combination of norepinephrine with phenylephrine versus norepinephrine with vasopressin in critically ill patients with septic shock: A retrospective study".
    Bulloch MN
    J Crit Care; 2023 Apr; 74():154239. PubMed ID: 36549962
    [No Abstract]   [Full Text] [Related]  

  • 7. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
    Russell JA; Lee T; Singer J; Boyd JH; Walley KR;
    Crit Care Med; 2017 Jun; 45(6):940-948. PubMed ID: 28333757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the addition of vasopressin to norepinephrine beneficial for the treatment of septic shock?
    Sandifer JP; Jones AE
    Ann Emerg Med; 2013 Nov; 62(5):534-535. PubMed ID: 23683544
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasopressor use in septic shock: an update.
    Leone M; Martin C
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of vasopressin in the management of septic shock.
    Mutlu GM; Factor P
    Intensive Care Med; 2004 Jul; 30(7):1276-91. PubMed ID: 15103461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal norepinephrine-equivalent dose to initiate epinephrine in patients with septic shock.
    Ammar MA; Limberg EC; Lam SW; Ammar AA; Sacha GL; Reddy AJ; Bauer SR
    J Crit Care; 2019 Oct; 53():69-74. PubMed ID: 31202160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
    Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin in septic shock.
    Russell JA
    Crit Care Med; 2007 Sep; 35(9 Suppl):S609-15. PubMed ID: 17713417
    [No Abstract]   [Full Text] [Related]  

  • 14. Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
    Oba Y; Lone NA
    J Crit Care; 2014 Oct; 29(5):706-10. PubMed ID: 24857641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indications of vasopressin in the management of septic shock].
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Ann Fr Anesth Reanim; 2003 Jul; 22(7):600-8. PubMed ID: 12946492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argument for Personalized Vasopressors in Septic Shock.
    Levine AR; Chow JH; McCurdy MT
    Crit Care Med; 2020 May; 48(5):e439. PubMed ID: 32301793
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasopressin in septic shock: clinical equipoise mandates a time for restraint.
    Russell JA
    Crit Care Med; 2003 Nov; 31(11):2707-9. PubMed ID: 14605551
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical review: Vasopressin and terlipressin in septic shock patients.
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Crit Care; 2005 Apr; 9(2):212-22. PubMed ID: 15774080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction.
    Ducrocq N; Kimmoun A; Furmaniuk A; Hekalo Z; Maskali F; Poussier S; Marie PY; Levy B
    Anesthesiology; 2012 May; 116(5):1083-91. PubMed ID: 22407285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of short-term vasopressin infusion during severe septic shock.
    Patel BM; Chittock DR; Russell JA; Walley KR
    Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.